Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?

Authors: Romano Demicheli, Marco Fornili, Elia Biganzoli

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

The study estimates mortality dynamics (event-specific hazard rates over a follow-up time interval) for uveal melanoma.

Methods

Three thousands six hundred seventy two patients undergoing radical or conservative treatment for unilateral uveal melanoma, whose yearly follow-up data were reported in three published datasets, were analysed. Mortality dynamics was studied by estimating with the life-table method the discrete hazard rate for death. Smoothed curves were obtained by a Kernel-like smoothing procedure and a piecewise exponential regression model. The ratio deaths/patients at risk per year was the main outcome measure.

Results

The three explored hazard rate curves display a common bimodal pattern, with a sudden increase peaking at about three years, followed by reduction until the sixth-seventh year and a second surge peaking at about nine years after treatment.

Conclusions

The bimodal pattern of mortality indicates that uveal melanoma metastatic development cannot be explained by a continuous growth model. Similar metastasis dynamics have been reported for other tumours, including early breast cancer, for which it supported a paradigm shift to an interrupted growth model, the implications of which are episodes of ‘tumour dormancy’. We propose that the concepts of tumour homeostasis, tumour dormancy and enhancement of metastasis growth related to primary tumour removal, convincingly explaining the clinical behaviour of breast cancer, may be used for uveal melanoma as well. To confirm this proposition, a careful analysis of uveal melanoma metastasis dynamics is strongly warranted.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zimmerman LE, McLean IW, Foster WD: Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells?. Br J Ophthalmol. 1978, 62 (6): 420-425. 10.1136/bjo.62.6.420.CrossRefPubMedPubMedCentral Zimmerman LE, McLean IW, Foster WD: Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells?. Br J Ophthalmol. 1978, 62 (6): 420-425. 10.1136/bjo.62.6.420.CrossRefPubMedPubMedCentral
3.
go back to reference Singh AD, Rennie IG, Kivela T, Serengard S, Grossniklaus H: The Zimmerman-McLean-Foster hypothesis: 25 years later. Br J Ophthalmol. 2004, 88 (7): 962-967. 10.1136/bjo.2003.029058.CrossRefPubMedPubMedCentral Singh AD, Rennie IG, Kivela T, Serengard S, Grossniklaus H: The Zimmerman-McLean-Foster hypothesis: 25 years later. Br J Ophthalmol. 2004, 88 (7): 962-967. 10.1136/bjo.2003.029058.CrossRefPubMedPubMedCentral
4.
go back to reference Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G: Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumour dormancy. Breast Cancer Res Treat. 1996, 41 (2): 177-185. 10.1007/BF01807163.CrossRefPubMed Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G: Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumour dormancy. Breast Cancer Res Treat. 1996, 41 (2): 177-185. 10.1007/BF01807163.CrossRefPubMed
5.
go back to reference Demicheli R, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, Kelsey CR: Recurrence dynamics for non-small cell lung cancer: effect of surgery on the development of metastases. J Thorac Oncol. 2012, 7 (4): 723-730. 10.1097/JTO.0b013e31824a9022.CrossRefPubMed Demicheli R, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, Kelsey CR: Recurrence dynamics for non-small cell lung cancer: effect of surgery on the development of metastases. J Thorac Oncol. 2012, 7 (4): 723-730. 10.1097/JTO.0b013e31824a9022.CrossRefPubMed
6.
go back to reference Lama N, Boracchi P, Biganzoli E: Partial logistic relevance vector machines insurvival analysis. J Applied Statistics. 2011, 38 (11): 2445-2458. 10.1080/02664763.2011.559204.CrossRef Lama N, Boracchi P, Biganzoli E: Partial logistic relevance vector machines insurvival analysis. J Applied Statistics. 2011, 38 (11): 2445-2458. 10.1080/02664763.2011.559204.CrossRef
7.
go back to reference Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti , Bonadonna G: Local recurrences following mastectomy: support for the concept of tumour dormancy. J. Natl. Cancer Inst. 1994, 86 (1): 45-48. 10.1093/jnci/86.1.45.CrossRefPubMed Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti , Bonadonna G: Local recurrences following mastectomy: support for the concept of tumour dormancy. J. Natl. Cancer Inst. 1994, 86 (1): 45-48. 10.1093/jnci/86.1.45.CrossRefPubMed
8.
go back to reference Demicheli R, Retsky MW, Hrushesky WJM, Baum M: Tumor dormancy and surgery-driven dormancy interruption in breast cancer: learning from failures. Nature Clin Pract Oncol. 2007, 4 (12): 699-710. 10.1038/ncponc0999.CrossRef Demicheli R, Retsky MW, Hrushesky WJM, Baum M: Tumor dormancy and surgery-driven dormancy interruption in breast cancer: learning from failures. Nature Clin Pract Oncol. 2007, 4 (12): 699-710. 10.1038/ncponc0999.CrossRef
10.
go back to reference McLean IW, Foster WD, Zimmerman LE, Matin DG: Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci. 1980, 19 (7): 760-770.PubMed McLean IW, Foster WD, Zimmerman LE, Matin DG: Inferred natural history of uveal melanoma. Invest Ophthalmol Vis Sci. 1980, 19 (7): 760-770.PubMed
11.
go back to reference Benjamin B, Cumings JN, Goldsmith AJB, Sorsby A: Prognosis of uveal melanoma. Br J Ophthalmol. 1948, 32 (10): 729-747. 10.1136/bjo.32.10.729.CrossRefPubMedCentral Benjamin B, Cumings JN, Goldsmith AJB, Sorsby A: Prognosis of uveal melanoma. Br J Ophthalmol. 1948, 32 (10): 729-747. 10.1136/bjo.32.10.729.CrossRefPubMedCentral
12.
go back to reference Collaborative Ocular Melanoma Study Group: The COMS randomized trial of Iodine125 brachytherapy for choroidal melanoma. V. Twelve-year mortality rates and prognostic factors: COMS Report N° 28. Arch Ophthalmol. 2006, 124 (12): 1684-1693.CrossRef Collaborative Ocular Melanoma Study Group: The COMS randomized trial of Iodine125 brachytherapy for choroidal melanoma. V. Twelve-year mortality rates and prognostic factors: COMS Report N° 28. Arch Ophthalmol. 2006, 124 (12): 1684-1693.CrossRef
13.
go back to reference Collaborative Ocular Melanoma Study Group: The Collaborative Ocular Melanoma Study (COMS) randomized trial of Pre-enucleation Radiation for large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS Report N° 24. Am J Ophthalmol. 2004, 138 (6): 9364-9951. Collaborative Ocular Melanoma Study Group: The Collaborative Ocular Melanoma Study (COMS) randomized trial of Pre-enucleation Radiation for large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS Report N° 24. Am J Ophthalmol. 2004, 138 (6): 9364-9951.
14.
go back to reference Ramlau-Hansen H: Smoothing counting process intensities by means of Kernel functions. The Annals of Statistics. 1983, 11 (2): 453-466. 10.1214/aos/1176346152.CrossRef Ramlau-Hansen H: Smoothing counting process intensities by means of Kernel functions. The Annals of Statistics. 1983, 11 (2): 453-466. 10.1214/aos/1176346152.CrossRef
15.
go back to reference Burnham KP, Anderson DR: A Practical Information-Theoretic Approach. Model Selection and Multimodel Inference. 2002, New York, NY: Springer-Verlag, 2 Burnham KP, Anderson DR: A Practical Information-Theoretic Approach. Model Selection and Multimodel Inference. 2002, New York, NY: Springer-Verlag, 2
16.
go back to reference Boracchi P, Biganzoli E, Marubini E: Joint modelling of cause-specific hazard functions with cubic splines: an application to a large series of breast cancer patients. Comput Stat Data Analysis. 2003, 42 (1–2): 243-262.CrossRef Boracchi P, Biganzoli E, Marubini E: Joint modelling of cause-specific hazard functions with cubic splines: an application to a large series of breast cancer patients. Comput Stat Data Analysis. 2003, 42 (1–2): 243-262.CrossRef
17.
go back to reference Eilers PHC, Marx BD: Flexible smoothing with B-splines and penalties. Statist Sci. 1996, 11 (2): 89-121. 10.1214/ss/1038425655.CrossRef Eilers PHC, Marx BD: Flexible smoothing with B-splines and penalties. Statist Sci. 1996, 11 (2): 89-121. 10.1214/ss/1038425655.CrossRef
18.
go back to reference Collaborative Ocular Melanoma Study Group: Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: collaborative ocular melanoma study group report No 26. Arch Ophthalmol. 2005, 123 (12): 1639-1643.CrossRef Collaborative Ocular Melanoma Study Group: Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: collaborative ocular melanoma study group report No 26. Arch Ophthalmol. 2005, 123 (12): 1639-1643.CrossRef
19.
go back to reference Demicheli R, Valagussa P, Bonadonna G: Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy. Breast Cancer Res Treat. 2002, 75 (2): 127-134. 10.1023/A:1019659925311.CrossRefPubMed Demicheli R, Valagussa P, Bonadonna G: Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy. Breast Cancer Res Treat. 2002, 75 (2): 127-134. 10.1023/A:1019659925311.CrossRefPubMed
20.
go back to reference Demicheli R, Retsky MW, Hrushesky WJM, Baum M, Gukas ID: The effects of surgery on tumor growth: a century of investigations. Ann Oncol. 2008, 19 (11): 1821-1828. 10.1093/annonc/mdn386. PMID:18550576CrossRefPubMed Demicheli R, Retsky MW, Hrushesky WJM, Baum M, Gukas ID: The effects of surgery on tumor growth: a century of investigations. Ann Oncol. 2008, 19 (11): 1821-1828. 10.1093/annonc/mdn386. PMID:18550576CrossRefPubMed
21.
go back to reference Gamel JW, McLean IW, McCurdy JB: Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma. Cancer. 1993, 71 (7): 2299-2305. 10.1002/1097-0142(19930401)71:7<2299::AID-CNCR2820710721>3.0.CO;2-G.CrossRefPubMed Gamel JW, McLean IW, McCurdy JB: Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma. Cancer. 1993, 71 (7): 2299-2305. 10.1002/1097-0142(19930401)71:7<2299::AID-CNCR2820710721>3.0.CO;2-G.CrossRefPubMed
22.
go back to reference Damato B: Developments in the management of uveal melanoma. Clin Invest Ophthalmol. 2004, 32 (6): 639-647. Damato B: Developments in the management of uveal melanoma. Clin Invest Ophthalmol. 2004, 32 (6): 639-647.
23.
go back to reference Spagnolo F, Caltabiano G, Queirolo P: Uveal melanoma. Cancer Treat Rev. 2012, 38: 549-553. 10.1016/j.ctrv.2012.01.002.CrossRefPubMed Spagnolo F, Caltabiano G, Queirolo P: Uveal melanoma. Cancer Treat Rev. 2012, 38: 549-553. 10.1016/j.ctrv.2012.01.002.CrossRefPubMed
24.
go back to reference Demicheli R, Ardoino I, Biganzoli E, Boracchi P, Coradini D, Greco M, Moliterni A, Zambetti M, Valagussa P, Gukas ID, Bonadonna G: Recurrence and mortality for breast cancer patients undergoing mastectomy according to estrogen receptor status: different mortality pattern but comparable recurrence dynamics. Cancer Sci. 2010, 101: 826-830. 10.1111/j.1349-7006.2009.01472.x.CrossRefPubMed Demicheli R, Ardoino I, Biganzoli E, Boracchi P, Coradini D, Greco M, Moliterni A, Zambetti M, Valagussa P, Gukas ID, Bonadonna G: Recurrence and mortality for breast cancer patients undergoing mastectomy according to estrogen receptor status: different mortality pattern but comparable recurrence dynamics. Cancer Sci. 2010, 101: 826-830. 10.1111/j.1349-7006.2009.01472.x.CrossRefPubMed
25.
go back to reference Retsky M, Rogers R, Demicheli R, Hrushesky WGM, Gukas I, Vaidya JS, Baum M, Forget P, DeKock M, Pachmann K: NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012, [Epub ahead of print] PubMed PMID: 22622810 Retsky M, Rogers R, Demicheli R, Hrushesky WGM, Gukas I, Vaidya JS, Baum M, Forget P, DeKock M, Pachmann K: NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012, [Epub ahead of print] PubMed PMID: 22622810
Metadata
Title
Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?
Authors
Romano Demicheli
Marco Fornili
Elia Biganzoli
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-392

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine